---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-385477"
form_type: "8-K"
ticker: "ODTX"
cik: "0001882782"
company_name: "Odyssey Therapeutics, Inc."
filed_at: "2026-09-08T23:10:19+00:00"
generated_at: "2026-09-09T10:06:11.464221+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Odyssey Therapeutics posts corporate presentation; no financial details in 8-K

## Summary
- Odyssey Therapeutics posted a corporate presentation on its investor relations website on September 8, 2026.
- The 8-K filing only announces the posting; the presentation's content is not included in the filing.
- No financial results, guidance, or material business developments are disclosed in the filing.
- Investors should review the presentation on the company's IR page for any updates.

## SEC filing metadata
- accession: 0001193125-26-385477
- form_type: 8-K
- ticker: ODTX
- cik: 0001882782
- company_name: Odyssey Therapeutics, Inc.
- filed_at: 2026-09-08T23:10:19+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1882782/000119312526385477/0001193125-26-385477-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1882782/000119312526385477/odtx-20260908.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-385477
- JSON: https://secwatch.observer/filing/0001193125-26-385477.json
- Plain text: https://secwatch.observer/filing/0001193125-26-385477.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.